Quarterly report pursuant to Section 13 or 15(d)

Earnings (Loss) Per Share - Narrative (Details)

v3.20.2
Earnings (Loss) Per Share - Narrative (Details) - $ / shares
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Common stock, par value (in dollars per share) $ 0.01   $ 0.01   $ 0.01
Number of common stock warrant and common stock options exercised (in shares) 171,500 0 171,500 24,877  
Number of common stock issued for stock warrant and stock options exercised (in shares) 171,500 0 171,500 19,232  
Shares surrendered in lieu of cash payment (in shares) 0   0 5,645  
Common Stock          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Dilutive potential shares (in shares) 73,412,800 69,072,430 69,661,016 65,778,754